Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 DiabetesManuela Battaglia, Mark Peakman, Dorothy Becker et al.|Diabetes Care|2019Cited by 350
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J. Haller, Louis H. Philipson, S. Alice Long et al.|Diabetes|2019Cited by 132